MS COVID-19 Meeting – May 20 2020

Our May 20/21 meeting was hosted by Emmanuelle Waubant. We welcomed Gavin Giovanonni (UK) discussing anti-CD20 therapies and vaccine readiness. For Gavin’s up-to-date patient information go to http://www.ms-selfie.org. Jan Hillert (SE) gave an update on the Swedish Registry data. There is a predonderance of patients in Rituximab in the Swedish Registry who have tested positive for COVID-19, but this could just be due to ascertainment bias. Georgina Arrambide (SP, CEMCAT) spoke about neurological complications of COVID-19, and mechanisms of involvement. Seth Levin (US, Columbia University NYC) spoke about the MS ReCOV study. For people in the US who wish to participate in the MS ReCOV study, links can be found here or here

Video

https://youtu.be/z4sRBQEv0yE

Please note, these videos are intended for a medical and scientific audience for educational purposes. All Registries collecting data on COVID-19 patients have been approved by research ethics committees/IRBs. Data are anonymised, no personal patient information is presented.